Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Craftport Cannabis Corp BHHKF


Primary Symbol: C.CFT

Craftport Cannabis Corp. is a Canada-based cannabis licensed producer operating out of Peachland, British Columbia. The Company is focused on the Canadian premium craft cannabis recreational market, utilizing an outsourced cultivation model. All of the Company’s cannabis licenses are held by its wholly owned subsidiary, Potanicals Green Growers Inc. The Peachland site is located at 4715 Paradise Valley Drive, Peachland, BC. It includes approximately 12,700 square foot production and processing facility situated on 20 acres of land. It operates an asset-light model whereby the Company purchases premium craft cannabis from other licensed cannabis producers that is being processed and packaged in Peachland and sold under the brand name Craftport Cannabis. The Company’s subsidiaries include 1139000 B.C. Ltd., 1161750 B.C. Ltd., and Canada Bond Biotechnology Co., Ltd.


CSE:CFT - Post by User

Bullboard Posts
Post by STOCKRUSon May 07, 2019 10:48pm
38 Views
Post# 29722842

CANNABIS NEWS - Benchmark Signs Strategic China Cooperation

CANNABIS NEWS - Benchmark Signs Strategic China Cooperation Vancouver, B.C. May 7, 2019 – Benchmark Botanics, Inc. (CSE: BBT) (FSE: BBW) (OTC: BHHKF) ("Benchmark" or the "Company") a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it has signed a non-binding letter of intent of strategic cooperation with China-based Zhejiang Yatai Pharmaceutical Co., Ltd. (“Zhejiang Yatai “), a publicly listed company on the Shenzhen Stock Exchange (stock code: 002370), to promote and conduct research and development, production, extraction and the commercial application of CBD and its derivative products for medical applications. Benchmark and Zhejiang Yatai agree to create, develop and market a variety of high content cannabinoid based (“CBD”) pharmaceuticals, natural health products and cosmetics for international markets.

https://benchmarkbotanics.com/investors/news/news-2019/83-benchmark-signs-a-letter-of-intent-of-strategic-cooperation-with-china-based-zejiang-yatai-pharmaceutical.html
Bullboard Posts